PMN (STOCKS)
ProMIS Neurosciences Inc. Common Shares (ON)
$14.580000
-0.030000 (-0.21%)
Prev close: $14.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Neil K. Warma
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $32.35M
- Employees
- 8
- P/E (TTM)
- -0.80
- P/B (TTM)
- 3.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-6.00 | $-6.14 | +0.1441 | +2.35% |
|
Jun 2025 (Q2)
|
$-7.25 | $-4.42 | -2.8312 | -64.07% |
|
Mar 2025 (Q1)
|
$-5.25 | $-3.03 | -2.2200 | -73.27% |
|
Dec 2024 (Q4)
|
$-0.25 | $-3.54 | +3.2850 | +92.93% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.11M |
| Operating Expenses | $35.40M |
| Research and Development | $28.34M |
| Other Operating Expenses | $7.06M |
| Operating Income/Loss | -$35.40M |
| Income/Loss From Continuing Operations After Tax | -$29.28M |
| Income/Loss From Continuing Operations Before Tax | -$29.28M |
| Net Income/Loss | -$29.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$29.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$29.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.80 |
| Diluted Earnings Per Share | -$0.80 |
| Basic Average Shares | 40,044,959 |
| Diluted Average Shares | 39,864,372 |
| Assets | $21.46M |
| Current Assets | $21.46M |
| Noncurrent Assets | $0.00 |
| Liabilities | $12.27M |
| Current Liabilities | $12.21M |
| Accounts Payable | $4.21M |
| Other Current Liabilities | $8.00M |
| Noncurrent Liabilities | $59.75K |
| Equity | $9.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.19M |
| Liabilities And Equity | $21.46M |
| Net Cash Flow From Operating Activities | -$27.55M |
| Net Cash Flow From Operating Activities, Continuing | -$27.55M |
| Net Cash Flow From Investing Activities | $6.83M |
| Net Cash Flow From Investing Activities, Continuing | $6.83M |
| Net Cash Flow From Financing Activities | $21.41M |
| Net Cash Flow From Financing Activities, Continuing | $21.41M |
| Net Cash Flow | $693.02K |
| Net Cash Flow, Continuing | $693.02K |
| Comprehensive Income/Loss | -$29.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$29.28M |
| Other Comprehensive Income/Loss | $0.00 |